PATENT CLAIM ANALYSIS

Application Number: 15763676
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "322000"]

Abstract:
Disclosed in the present invention are a salt type and crystal type of 4H-pyrazolo[1, 5-alpha]benzimidazole compound and the preparation method and intermediate thereof.

Claim (Index 15):
A process for treating a disease associated with PARP receptor in a subject in need thereof, comprising: administering an effective amount of crystal type A according to  claim 8  to the subject.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 90.0
- Lexical Diversity: 1.16
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15514326', '14415891', '15573061', '15566872', '11286055']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7520211598660451
- 35 USC 102 Novelty (BERT): 0.5070786048885471
- Combined Prediction Score: 0.7275269043682953
- Mean Citation Score: 222.123906
- Max Citation Score: 232.25311
- Similarity Product: 141.8908829505086

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test